The International Tinnitus Journal

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44 7367 141882

Original Paper - The International Tinnitus Journal (2018) Volume 22, Issue 2

Tinnitus Treatment with Misoprost: A Blinded and Placebo Controlled Study

Introduction: The purpose of conducting research was to investigate the efficacy of the misoprost as a treatment modality for tinnitus.
Methodology: A sample of 130 subjects with hearing loss and tinnitus were randomly segregated into control (N=70) and misoprost group (N=60). Misoprost group were administered a dosage of 200 μg per day of misoprostol and it was increased to 1600 ug, for 3 months and Control group (70 subjects) received the 200 ug/day of placebo tablets. Pre and post assessment on audiological measures (tinnitus pitch and loudness matching), Tinnitus handicap inventory and Visual analogue scale was performed.
Results and Discussion: Statistically significant differences were observed between pre-and post-misoprost treatment in terms of tinnitus pitch and loudness (p<0.001) for misoprost group. On visual analogue scale 33.3% of misoprost group subjects reported improvement; also 50% of them reported reduction in scores of tinnitus handicap inventory post-treatment. The results suggest that misoprost might act as an effective treatment modality for alleviation of tinnitus; however larger randomized controlled clinical trials are required to support these findings.

Author(s): Anuradha Sharma, Jaimanti Bakshi, Sanjay Munjal

Abstract Full Text PDF

Get the App